Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Rheumatol ; 4: 17, 2020.
Article in English | MEDLINE | ID: mdl-32161847

ABSTRACT

BACKGROUND: Black and Hispanic patients with osteoarthritis have more pain and worse function than Whites at the time of arthroplasty. Whether this is true for patients with rheumatoid arthritis (RA) is unknown. METHODS: This cross-sectional study used data on RA patients acquired between October 2013 and November 2018 prior to elective total knee (TKA) or hip arthroplasty (THA). Pain, function, and disease activity were assessed using the visual analogue scale (VAS), the Multidimensional Health Assessment Questionnaire (MDHAQ), and the Disease Activity Score (DAS28-ESR). We linked the cases to census tracts using geocoding to determine the community poverty level. Race, education, income, insurance and medications were collected via self-report. Using multivariable linear and logistic models we examined whether minority status predicted pain, function and RA disease activity at the time of arthroplasty. RESULTS: Thirty seven (23%) of the 164 patients were Black or Hispanic (minorities). The MDHAQ and DAS28-ESR were not significantly worse while VAS pain score was significantly worse in minority patients (p = 0.03). There was no significant difference in education between the groups. Insurance varied significantly; 29% of minority patients had Medicaid vs. 0% of Whites (p < 0.0001). In the multivariable analyses minority status was not significantly associated with DAS28-ESR [p = 0.66], MDHAQ [p = 0.26], or VAS pain [p = 0.18]. CONCLUSIONS: For Black and/or Hispanic patients with RA undergoing THA or TKA at a high-volume specialty hospital, unlike Black or Hispanic patients with osteoarthritis (OA), there was no association with worse pain, function, or RA disease activity at the time of elective arthroplasty.

2.
Prostate Cancer Prostatic Dis ; 7(1): 63-72, 2004.
Article in English | MEDLINE | ID: mdl-14999241

ABSTRACT

Despite the potency with which dendritic cells (DCs) are able to utilize the exogenous MHC I antigen cross-presentation pathway to cross-present antigen for the activation of killer T cells in model systems, concern about defects in immune function in cancer patients has led to uncertainty regarding whether immune cells derived from patients can effectively be used to generate tumor vaccines. We have undertaken a careful analysis of the potency of using DCs obtained from prostate cancer patients to cross-present antigen derived from human prostate tumor cells for the activation of antigen-specific T cells. Such DCs can be matured ex vivo into functionally active cells and are capable of cross-presenting influenza antigen derived from internalized apoptotic prostate tumor cells. Importantly, we demonstrate effective stimulation of both CD4+ and CD8+ T cells, as evident by production of IFN-gamma, and the ability of CD8+ T cells to differentiate into effector CTLs. These results, defining conditions in which prostate cancer patient DCs can efficiently utilize the cross-presentation pathway and in which apoptotic tumor can serve as a source of antigen for DCs to activate T cells, demonstrate that this system warrants clinical study as a potential immunotherapy.


Subject(s)
Apoptosis , Cross-Priming , Dendritic Cells/immunology , Immunotherapy/methods , Prostatic Neoplasms/immunology , Prostatic Neoplasms/pathology , Antigens, Neoplasm , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Humans , Male , Tumor Cells, Cultured
6.
Int J Psychoanal ; 79 ( Pt 6): 1221-2, 1998 Dec.
Article in English | MEDLINE | ID: mdl-10036631
7.
J AHIMA ; 67(9): 86-7, 1996 Oct.
Article in English | MEDLINE | ID: mdl-10161444
8.
Biomaterials ; 11: 88-91, 1990 Jul.
Article in English | MEDLINE | ID: mdl-2397268

ABSTRACT

Three base alumina ceramics with dispersoids: monoclinic zirconia alumina (A5Z), tetragonal zirconia alumina (A20Z) and aluminalon (Aa20) have been investigated because of their improved mechanical properties with reference to pure alumina (AI203). Bending strength and fracture toughness are twice higher than alumina for the most toughened. These two parameters were measured by four-points bending tests after 1 week, 1, 2, 3, 6, 12 months of non loaded in vivo aging in wistar rats. They showed a little decrease for AI203 and Aa20 and a total stability for A5Z and A20Z even after one year. For tribologic study of the ceramic/polyethylene combination, cylinder against plane and pin on flat tests were conducted on an alternative movement with hip parameters of speed and load in presence of ringer solution. For the most representative test (pin on disk), the friction coefficients were nearly the same for all materials but UHMWPE wear volume was twice lower against A20Z than against AI203. A20Z/UHMWPE combination would be very interesting as new friction couple for total hip arthroplasty. Further studies are currently conducted.


Subject(s)
Aluminum Oxide , Aluminum , Biocompatible Materials , Ceramics , Materials Testing , Animals , Molecular Weight , Polyethylenes , Prosthesis Failure , Rats , Rats, Inbred Strains , Stress, Mechanical , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...